AllianceBernstein’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Buy
34,489
+243
+0.7% +$21.5K ﹤0.01% 1824
2025
Q4
$2.75M Sell
34,246
-35,398
-51% -$2.96M ﹤0.01% 1829
2025
Q3
$6.8M Sell
69,644
-1,944
-3% -$157K ﹤0.01% 1387
2025
Q2
$4.99M Buy
71,588
+10,068
+16% +$574K ﹤0.01% 1481
2025
Q1
$3.06M Sell
61,520
-4,622
-7% -$292K ﹤0.01% 1676
2024
Q4
$4.62M Buy
66,142
+3,288
+5% +$273K ﹤0.01% 1526
2024
Q3
$6.59M Sell
62,854
-44
-0.1% -$5.15K ﹤0.01% 1397
2024
Q2
$8.94M Sell
62,898
-10,802
-15% -$1.25M ﹤0.01% 1225
2024
Q1
$8.22M Buy
73,700
+228
+0.3% +$27.2K ﹤0.01% 1256
2023
Q4
$9.53M Buy
73,472
+9,187
+14% +$1.27M ﹤0.01% 1183
2023
Q3
$10.5M Buy
64,285
+20,588
+47% +$3.62M ﹤0.01% 1066
2023
Q2
$8.01M Sell
43,697
-7,923
-15% -$1.14M ﹤0.01% 1235
2023
Q1
$6.88M Buy
51,620
+6,446
+14% +$757K ﹤0.01% 1271
2022
Q4
$3.59M Sell
45,174
-61
-0.1% -$4.3K ﹤0.01% 1583
2022
Q3
$2.74M Buy
45,235
+83
+0.2% +$5.36K ﹤0.01% 1683
2022
Q2
$2.48M Buy
45,152
+537
+1% +$31.1K ﹤0.01% 1814
2022
Q1
$3.37M Sell
44,615
-1,465
-3% -$100K ﹤0.01% 1781
2021
Q4
$3.44M Buy
46,080
+1,645
+4% +$97.5K ﹤0.01% 1825
2021
Q3
$2.09M Sell
44,435
-1,630
-4% -$70.9K ﹤0.01% 2144
2021
Q2
$1.86M Buy
46,065
+4,280
+10% +$177K ﹤0.01% 2238
2021
Q1
$1.72M Buy
41,785
+365
+0.9% +$13.6K ﹤0.01% 2182
2020
Q4
$1.21M Hold
41,420
﹤0.01% 2217
2020
Q3
$911K Sell
41,420
-970
-2% -$24.7K ﹤0.01% 2229
2020
Q2
$1.18M Buy
42,390
+1,090
+3% +$26.6K ﹤0.01% 2119
2020
Q1
$756K Buy
41,300
+100
+0.2% +$2.32K ﹤0.01% 2163
2019
Q4
$993K Buy
41,200
+200
+0.5% +$4.21K ﹤0.01% 2287
2019
Q3
$701K Sell
41,000
-7,600
-16% -$121K ﹤0.01% 2403
2019
Q2
$731K Buy
48,600
+13,400
+38% +$239K ﹤0.01% 2448
2019
Q1
$708K Hold
35,200
﹤0.01% 2400
2018
Q4
$627K Buy
35,200
+3,900
+12% +$69.3K ﹤0.01% 2386
2018
Q3
$615K Sell
31,300
-3,800
-11% -$78.3K ﹤0.01% 2545
2018
Q2
$695K Hold
35,100
﹤0.01% 2483
2018
Q1
$863K Hold
35,100
﹤0.01% 2323
2017
Q4
$1.01M Hold
35,100
﹤0.01% 2263
2017
Q3
$960K Hold
35,100
﹤0.01% 2299
2017
Q2
$735K Buy
+35,100
New +$742K ﹤0.01% 2454
2017
Q1
Sell
-11,100
Closed -$162K 2989
2016
Q4
$162K Hold
11,100
﹤0.01% 2930
2016
Q3
$147K Buy
11,100
+1,400
+14% +$16.2K ﹤0.01% 2898
2016
Q2
$104K Buy
9,700
+925
+11% +$9.92K ﹤0.01% 2905
2016
Q1
$98K Hold
8,775
﹤0.01% 2821
2015
Q4
$91K Sell
8,775
-2,375
-21% -$25.2K ﹤0.01% 2856
2015
Q3
$119K Sell
11,150
-2,000
-15% -$24.4K ﹤0.01% 2859
2015
Q2
$156K Sell
13,150
-1,600
-11% -$18.5K ﹤0.01% 2917
2015
Q1
$140K Hold
14,750
﹤0.01% 2944
2014
Q4
$151K Sell
14,750
-725
-5% -$6.29K ﹤0.01% 2886
2014
Q3
$123K Sell
15,475
-1,750
-10% -$13.1K ﹤0.01% 2913
2014
Q2
$138K Sell
17,225
-4,865
-22% -$36.3K ﹤0.01% 2916
2014
Q1
$190K Sell
22,090
-10,200
-32% -$93.8K ﹤0.01% 2780
2013
Q4
$315K Sell
32,290
-9,225
-22% -$83.7K ﹤0.01% 2653
2013
Q3
$350K Sell
41,515
-7,935
-16% -$64.3K ﹤0.01% 2656
2013
Q2
$360K Buy
+49,450
New +$287K ﹤0.01% 2644

Other funds holding ACLS

AllianceBernstein's ACLS Position: Q1 2026 in Review

AllianceBernstein increased its Axcelis (ACLS) stake by 0.71% in Q1 2026, buying an estimated $21.5K and bringing the position to 34,489 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

AllianceBernstein first reported a position in ACLS in Q2 2013 and has held it in 51 quarters since. The position peaked at $10.5M in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • AllianceBernstein held 34,489 shares of Axcelis worth $2.77M as of Q1 2026.
  • AllianceBernstein bought 243 Axcelis shares in Q1 2026, an estimated $21.5K.
  • Axcelis made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1824 holding.
  • AllianceBernstein first reported a position in Axcelis in Q2 2013 and has held it in 51 quarters since.
  • AllianceBernstein's Axcelis position peaked at $10.5M in Q3 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.